John R. Murphy's Insider Trades & SAST Disclosures
John R. Murphy's most recent trade in Cadrenal Therapeutics Inc was a trade of 20,000 Stock Options done . Disclosure was reported to the exchange on Jan. 23, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John R. Murphy.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cadrenal Therapeutics Inc | John Raymond Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 20,000 | 20,000 | - | - | Stock Options | |
| O`Reilly Automotive, Inc. | John Raymond Murphy | Director | Grant, award, or other acquisition of securities at price $ 1012.06 per share. | 17 May 2024 | 173 | 1,123 (0%) | 0% | 1012.1 | 175,086 | Common stock |
| O`Reilly Automotive, Inc. | John Raymond Murphy | Director | Sale of securities on an exchange or to another person at price $ 1039.28 per share. | 13 Feb 2024 | 269 | 950 (0%) | 0% | 1039.3 | 279,567 | Common stock |
| Cadrenal Therapeutics Inc | Raymond Murphy John | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 100,000 | 100,000 | - | - | Stock Options | |
| O`Reilly Automotive, Inc. | John Raymond Murphy | Director | Sale of securities on an exchange or to another person at price $ 929.66 per share. | 31 Oct 2023 | 250 | 1,219 (0%) | 0% | 929.7 | 232,416 | Common stock |
| Cadrenal Therapeutics Inc | John Murphy Raymond | Director | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 04 Oct 2023 | 17,331 | 612,123 | - | 0.7 | 12,132 | Common Stock |
| Cadrenal Therapeutics Inc | Raymond Murphy John | Director | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 04 Oct 2023 | 2,669 | 614,792 | - | 0.7 | 1,842 | Common Stock |
| Summit Materials Inc - Ord... | John Raymond Murphy | Director | 29 Sep 2023 | 4,274 | 0 | - | - | LP Units of Summit Materials Holdings L.P. | ||
| Summit Materials Inc - Ord... | John Raymond Murphy | Director | 29 Sep 2023 | 4,274 | 21,499 (0%) | 0% | - | Class A Common Stock | ||
| O`Reilly Automotive, Inc. | John Raymond Murphy | Director | Grant, award, or other acquisition of securities at price $ 954.30 per share. | 19 May 2023 | 169 | 1,469 (0%) | 0% | 954.3 | 161,277 | Common stock |
| O`Reilly Automotive, Inc. | John Raymond Murphy | Director | Sale of securities on an exchange or to another person at price $ 924.56 per share. | 02 May 2023 | 300 | 1,300 (0%) | 0% | 924.6 | 277,368 | Common stock |
| Cadrenal Therapeutics Inc | John Raymond Murphy | Director | Purchase of securities on an exchange or from another person at price $ 1.39 per share. | 21 Mar 2023 | 10,000 | 594,792 | - | 1.4 | 13,900 | Common Stock |
| Cadrenal Therapeutics Inc | John Raymond Murphy | Director | Purchase of securities on an exchange or from another person at price $ 1.67 per share. | 16 Mar 2023 | 20,000 | 574,792 | - | 1.7 | 33,398 | Common Stock |
| Summit Materials Inc - Ord... | John Raymond Murphy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 3,815 | 0 | - | - | Restricted Stock Units | |
| Summit Materials Inc - Ord... | John Raymond Murphy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 3,815 | 17,225 (0%) | 0% | - | Class A Common Stock | |
| Summit Materials Inc - Ord... | John Raymond Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 4,038 | 4,038 | - | - | Restricted Stock Units | |
| O`Reilly Automotive, Inc. | John Raymond Murphy | Director | Sale of securities on an exchange or to another person at price $ 850.06 per share. | 14 Feb 2023 | 300 | 1,600 (0%) | 0% | 850.1 | 255,018 | Common stock |
| Cadrenal Therapeutics Inc | John Raymond Murphy | Director | 24 Jan 2023 | 514,792 | 554,792 | - | - | Common Stock | ||
| Cadrenal Therapeutics Inc | John Raymond Murphy | Director | 24 Jan 2023 | 514,792 | 0 | - | - | Convertible Promissory Note | ||
| O`Reilly Automotive, Inc. | John R. Murphy | Director | Sale of securities on an exchange or to another person at price $ 705.49 per share. | 02 Aug 2022 | 300 | 1,900 (0%) | 0% | 705.5 | 211,647 | Common stock |
| O`Reilly Automotive, Inc. | John R. Murphy | Director | Grant, award, or other acquisition of securities at price $ 635.62 per share. | 13 May 2022 | 248 | 2,200 (0%) | 0% | 635.6 | 157,634 | Common stock |
| Summit Materials Inc - Ord... | John R. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 3,815 | 3,815 | - | - | Restricted Stock Units | |
| Summit Materials Inc - Ord... | John R. Murphy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 4,374 | 0 | - | - | Restricted Stock Units | |
| Summit Materials Inc - Ord... | John R. Murphy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 4,374 | 13,216 (0%) | 0% | - | Class A Common Stock | |
| Summit Materials Inc - Ord... | John R. Murphy | Director | Sale of securities on an exchange or to another person at price $ 37.99 per share. | 08 Nov 2021 | 5,137 | 8,842 (0%) | 0% | 38.0 | 195,155 | Class A Common Stock |
| O`Reilly Automotive, Inc. | John R. Murphy | Director | Grant, award, or other acquisition of securities at price $ 553.33 per share. | 14 May 2021 | 272 | 1,952 (0%) | 0% | 553.3 | 150,506 | Common stock |
| O`Reilly Automotive, Inc. | John R. Murphy | Director | Sale of securities on an exchange or to another person at price $ 561.83 per share. | 11 May 2021 | 472 | 1,680 (0%) | 0% | 561.8 | 265,186 | Common stock |
| Summit Materials Inc - Ord... | John R. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 4,374 | 4,374 | - | - | Restricted Stock Units | |
| Summit Materials Inc - Ord... | John R. Murphy | Director | Sale of securities on an exchange or to another person at price $ 27.64 per share. | 18 Mar 2021 | 7,000 | 13,979 (0%) | 0% | 27.6 | 193,480 | Class A Common Stock |
| Summit Materials Inc - Ord... | John R. Murphy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2021 | 5,342 | 20,979 (0%) | 0% | - | Class A Common Stock | |
| Summit Materials Inc - Ord... | John R. Murphy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2021 | 5,342 | 0 | - | - | Restricted Stock Units | |
| O`Reilly Automotive, Inc. | John R. Murphy | Director | Sale of securities on an exchange or to another person at price $ 452.34 per share. | 12 Nov 2020 | 200 | 2,152 (0%) | 0% | 452.3 | 90,468 | Common stock |
| O`Reilly Automotive, Inc. | John R. Murphy | Director | Sale of securities on an exchange or to another person at price $ 470.47 per share. | 04 Aug 2020 | 250 | 2,352 (0%) | 0% | 470.5 | 117,618 | Common stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges